Healio
Healio
More about

Pediatric-Onset Multiple Sclerosis

CME
Video

Expert Insights on COVID-19 Prophylaxis in Patients With Multiple Sclerosis and Related Disorders

Expert Insights on COVID-19 Prophylaxis in Patients With Multiple Sclerosis and Related Disorders
1.50 CME
1.50 NCPD
90 MINS
$0 FEE
Clinical Guidance
Multiple Sclerosis
Assessment and Treatment

Assessment of Multiple Sclerosis

Pavan Bhargava, MD

Free clinical reference tool that includes treatment options; diagnosis information; guidelines; and more.

Clinical Guidance
Multiple Sclerosis
Overview

Pathophysiology

Pavan Bhargava, MD

Free clinical reference tool that includes treatment options; diagnosis information; guidelines; and more.

Clinical Guidance
Multiple Sclerosis
Overview

Etiology and Risk Factors

Pavan Bhargava, MD

Free clinical reference tool that includes treatment options; diagnosis information; guidelines; and more.

Clinical Guidance
Multiple Sclerosis
Overview

Global Prevalence and Epidemiology

Pavan Bhargava, MD

Free clinical reference tool that includes treatment options; diagnosis information; guidelines; and more.

Clinical Guidance
Multiple Sclerosis
Overview

Definition and Classification

Pavan Bhargava, MD

Free clinical reference tool that includes treatment options; diagnosis information; guidelines; and more.

News
February 22, 2024
2 min read
Save

Highly effective treatments for pediatric onset MS linked to best outcomes at 2 years

Highly effective treatments for pediatric onset MS linked to best outcomes at 2 years

For individuals with pediatric-onset multiple sclerosis, treatment with commonly known highly effective therapies was associated with reduced relapse risk and optimal outcome within the first 2 years, researchers wrote in JAMA Neurology.